SATSUMA PHARMACEUTICALS INC's ticker is STSA and the CUSIP is 80405P107. A total of 63 filers reported holding SATSUMA PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $157 | -100.0% | 174,994 | +181.7% | 0.00% | – |
Q3 2022 | $373,000 | +33.2% | 62,116 | +3.3% | 0.00% | – |
Q3 2021 | $280,000 | -72.0% | 60,108 | -57.6% | 0.00% | -100.0% |
Q2 2021 | $1,000,000 | +1036.4% | 141,783 | +849.7% | 0.00% | – |
Q1 2021 | $88,000 | -50.8% | 14,930 | -67.5% | 0.00% | – |
Q3 2020 | $179,000 | -13.5% | 45,926 | +538.7% | 0.00% | – |
Q2 2020 | $207,000 | -60.6% | 7,190 | -79.5% | 0.00% | -100.0% |
Q3 2019 | $525,000 | – | 35,038 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CAXTON CORP | 870,820 | $13,071,000 | 14.74% |
RA Capital Management | 4,681,858 | $70,275,000 | 4.19% |
Cormorant Asset Management, LP | 858,382 | $12,884,000 | 0.78% |
Monashee Investment Management LLC | 62,500 | $938,000 | 0.43% |
TPG Group Holdings (SBS) Advisors, Inc. | 3,771,878 | $56,616,000 | 0.42% |
DC Investments Management, LLC | 35,502 | $533,000 | 0.31% |
Eventide Asset Management | 425,000 | $6,379,000 | 0.21% |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 610,000 | $9,156,000 | 0.02% |
Weiss Asset Management LP | 14,150 | $212,000 | 0.02% |
Zimmer Partners, LP | 100,000 | $1,501,000 | 0.02% |